Trial Profile
Study of ultrasound detected residual synovitis treated with combination of anti-rheumatic therapy and denosumab in rheumatoid arthritis
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jan 2020
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 27 Jan 2020 Status changed from recruiting to discontinued.
- 03 Aug 2017 New trial record